Differences between this trial and earlier studies may reflect variations in patient populations, treatment duration, or study design, including the distinction between prevention and treatment of symptomatic disease
Study 1 included participants who were unwilling or unable to use PAP therapy, and study 2 included participants who had been using PAP therapy for at least 3 months at screening, and who planned to continue PAP for the duration of the trial
Meanwhile, VPA was superior in restoring the integrity and thickness of the pyramidal cells and neuron cell components, including the nucleus and mitochondria
sermorelin is an unmodified GHRH(129) fragment with older, mostly pediatric human data and no current approved product
In July 2025, the FDA indicated that generic versions of liraglutide (Victoza) and brand Saxenda are available